Efficacy and Safety of Risankizumab in Genital or Scalp Psoriasis in the UnlIMMited Phase 4 Randomized Clinical Trial at Week 16

Authors

Manish Patel (ORCID: https://orcid.org/0009-0002-6139-6873)
G. Michael Lewitt
Jerry Bagel (ORCID: https://orcid.org/0000-0001-5241-0915)
Arathi R. Setty
Navid Ezra
Eingun James Song (ORCID: https://orcid.org/0000-0001-9735-0100)
Lindsay Ackerman (ORCID: https://orcid.org/0009-0002-3373-3887)
Chenyang Duan (ORCID: https://orcid.org/0000-0002-6081-5987)
Benjamin D. Ehst (ORCID: https://orcid.org/0000-0001-6380-5226)
Phoebe Rich
Toni Anschutz (ORCID: https://orcid.org/0009-0004-3594-5028)
Greg St. John
Brad Glick
Doug Ashley
Brenton Bialik

Institutions

Frontier Hospital (ZA)
AbbVie (United States) (US)
VA New Jersey Health Care System (US)
Oregon Dermatology & Research Center (US)
Clinical Pharmacology of Miami (US)
Denova Research (US)
Oregon Medical Research Center (US)
Los Angeles Clinical Trials (US)
Dermatology Specialists (US)

Publication Details

Journal: Dermatology and Therapy
Published: 2025-10-25
DOI: https://doi.org/10.1007/s13555-025-01544-6
Primary Topic: Psoriasis: Treatment and Pathogenesis
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Efficacy and Safety of Risankizumab in Genital or Scalp Psoriasis in the UnlIMMited Phase 4 Randomized Clinical Trial at Week 16

Manish Patel, G. Michael Lewitt, Jerry Bagel, Arathi R. Setty et al.

Oct 25, 2025

Dermatology and Therapy

Psoriasis: Treatment and Pathogenesis

article

Efficacy and Safety of Risankizumab in Genital or Scalp Psoriasis in the UnlIMMited Phase 4 Randomized Clinical Trial at Week 16

Manish Patel, G. Michael Lewitt, Jerry Bagel, Arathi R. Setty, Navid Ezra, Eingun James Song, Lindsay Ackerman, Chenyang Duan, Benjamin D. Ehst, Phoebe Rich, Toni Anschutz, Greg St. John, Brad Glick, Doug Ashley, Brenton Bialik

October 25, 2025article en

Abstract

No abstract available for this paper.

Dermatology and TherapyVol. 16(1)

Frontier Hospital (ZA), AbbVie (United States) (US), VA New Jersey Health Care System (US), Oregon Dermatology & Research Center (US), Clinical Pharmacology of Miami (US), Denova Research (US), Oregon Medical Research Center (US), Los Angeles Clinical Trials (US), Dermatology Specialists (US)

Openalex Percentile: Top 68%

Psoriasis: Treatment and Pathogenesis

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Efficacy and Safety of Risankizumab in Genital or Scalp Psoriasis in the UnlIMMited Phase 4 Randomized Clinical Trial at Week 16 — Manish Patel, G. Michael Lewitt, et al. · Dermatology and Therapy (2025) | TGRS Research Map | TGRS